CLDX
Celldex Therapeutics, Inc.
Next earnings Aug 5, 2026 · consensus $-1.09 EPS, $974K rev
Last earnings -3.1% on 2026-05-07
$34.09
▲ +0.92%$34.09▲ +63.74%
over 1Y
L $20.01EODHDH $34.55
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.9%
1W+2.6%
1M+9.5%
3M+6.6%
YTD+25.1%
1Y+62.2%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 22 analysts
Buy
Conservative balance sheet (liabilities/equity 0.11x); but revenue fell -78.0% YoY.
Celldex Therapeutics, Inc. shows $1.54M in FY2025 revenue (-78.0% YoY), a -16748.0% net margin, and -49.1% ROE.
Sources: SEC EDGAR (CIK 0000744218, latest 10-Q filed 2026-05-07) · EODHD · as of 6/25/2026, 8:30:59 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.